24 news items
Page 2 of 2
3sikv41k8wjzn55wry1kcyjh431onwhr6wy9eta1wv ymon0zs
BMY
JNJ
LEGN
18 Mar 24
ODAC unanimously votes 11 to 0, supporting the favorable risk-benefit assessment of Carvykti based on results from
uilw49egr5l4x1qja5zuqs8vxc2mfyzcc8
BMY
14 Mar 24
escalation portion of the study assessed the safety and recommended dose for the subsequent Phase 2 expansion cohort. The Phase 2 portion of the study
hmslgxckc3aanfg7ra6fj6n
BMY
JNJ
LEGN
13 Mar 24
assessment of ciltacabtagene-autoleucel (cilta-cel) for the proposed indication.
Specifically, is the risk of early death associated
cqvi5qnql1c78nnpgep1ljb352z3 jl01m
BMY
7 Mar 24
overall survival (OS) and progression-free survival (PFS) assessed by Blinded Independent Central Review (BICR